SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-069892
Filing Date
2023-12-13
Accepted
2023-12-13 09:22:49
Documents
13
Period of Report
2023-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-20231212.htm   iXBRL 8-K 48011
2 EX-10.1 crsp-ex10_1.htm EX-10.1 75866
  Complete submission text file 0000950170-23-069892.txt   248786

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20231212_lab.xml EX-101.LAB 13779
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20231212.xsd EX-101.SCH 2464
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20231212_pre.xml EX-101.PRE 10524
7 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20231212_htm.xml XML 4500
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 231483105
SIC: 2836 Biological Products, (No Diagnostic Substances)